Worldwide, American foulbrood (AFB) is the most devastating bacterial disease of the honey bee (Apis mellifera). Because the distinction between AFB and powdery scale disease is no longer considered valid, the pathogenic agent has recently been reclassified as one species Paenibacillus larvae, eliminating the subspecies designations Paenibacillus larvae subsp. larvae and Paenibacillus larvae subsp. pulvifaciens. The creamy or dark brown, glue-like larval remains of infected larvae continue to provide the most obvious clinical symptom of AFB, although it is not conclusive. Several sensitive and selective culture media are available for isolation of this spore-forming bacterium, with the type of samples that may be utilized for detection of the organism being further expan ded. PCR methods for identification and genotyping of the pathogen have now been extensively developed. Nevertheless, biochemical profiling, bacteriophage sensitivity, immunotechniques and microscopy of suspect bacterial strains are entirely adequate for routine identification purposes.
Introduction
American foulbrood is an infectious disease of honey bees (Apis mellifera and Apis cerana) caused by the spore forming bacterium Paenibacillus larvae. It is characterized by the typical 'foul' putrescence emanating from hives containing infected brood and represents a serious, worldwide problem for apiculture (Ellis and Munn 2005) . AFB is classified on list B of the Office International des Epizooties (OIE), the World Organization for Animal Health. List B diseases are defined as transmissible diseases which are considered to be of socio-economic and/or public health importance within countries and which are significant in the international trade of animals and animal products.
In the past decade, considerable progress has been made in the understanding and taxonomic reclassification of the causative agent as well as the diagnosis of AFB. Traditional methods such as the recognition of typical clinical symptoms of infection, culture of P. larvae from diseased brood, and microscopy provide effective and inexpensive means of diagnosing the disease. In addition, improved detection of P. larvae from brood and bee products using molecular techniques, immunotechniques and superior culture techniques have emerged in recent years providing a broader range of methodologies for effi cient diagnosis. This review outlines current recommen ded strategies for the diagnosis of AFB which takes into consideration the reclassification of the causative agent to the single species P. larvae. White (1906) described the species Bacillus larvae, the pathogenic agent of AFB. Forty-four years later Katznelson (1950) described a closely related species, Bacillus pulvifaciens, also isolated from bee larvae but in association with a rare disease called 'powdery scale'. Both species were transferred to a new genus Paenibacillus in 1993 (Ash et al. 1993) and later taxonomic revisions described them as being the same species, P. larvae, but separated at the sub species level, i.e. P. larvae ssp. larvae (Pll) (formerly Bacillus larvae} and P. larvae ssp. pulvifaciens (Pip} (formerly Bacil lus pulvifaciens} (Heyndrickx et al. 1996) . Genersch et al. (2006) proposed to eliminate the sub species designation based on a polyphasic taxonomic study including colony and spore morphology, biochemi cal profiles using API systems, SDS-PAGE of whole cell proteins, and rep-PCR fingerprinting and pulsed-field gel electrophoresis (PFGE) of bacterial DNA. In addition, they found that experimental infection with strains identi fied as Pip also leads to the formation of glue-like larval remains that dry down to a hard scale as described for AFB. Moreover, they found that Pip strains could be even more virulent with no indication of powdery scale symp toms being observed during their trials. By publishing the proposed reclassification in the official journal of the International Committee on Systematics of Prokaryotes the elimination of the subspecies epithet for P. larvae is now validated ). Consequently, P. larvae should be considered the full and correct desig nation for the pathogenic agent of AFB.
Pathogenic agent

Clinical symptoms
Traditionally, the creamy or dark brown glue-like larval remains that can be drawn out as a thread (ropiness) with a matchstick represent the most obvious clinical symptom of AFB ( Fig. 1 ). This symptom is so readily recognized that 'the matchstick test' is often performed by the beekeeper within the apiary and forms part of the first-line warning system against AFB. However, where P. alvei is a secondary invader in cases of European foul brood, clinical signs of infection may look similar to those seen with AFB. This similarity may also involve ropiness of dead brood (Gochnauer et al. 1979) . Ropy remains of AFB-infected brood are principally from older larvae that die in the upright position, most often after the brood cell has been capped, but larval remains can also be found in open cells. As the infection progresses, cell cappings harbouring dead brood appear greasy, dark ened and become concave and punctured with small holes. The larval remains dry down to a flat scale tightly attached to the lower brood cell wall. Very characteristic, but not commonly seen, is the decomposition of the pupal stage in which the tongue protrudes from the head, extending to the top of the brood cell or angling back towards the bottom of the cell. The pupal tongue may also persist in the dried scale.
In addition to the clinical symptoms associated with older larvae and pupae, there is the less noticeable but rapid mortality associated with young larvae, still curled at the base of the uncapped cell. Although these un capped, infected larvae exhibit no obvious visual symp toms, adult worker bees will readily remove them, leaving only empty cells (Brodsgaard et al. 2000) . The resulting mottled or spotty appearance of the brood is therefore the result of a varying pattern of healthy capped brood, uncapped cells containing the remains of diseased larvae and empty cells. Similar pathology may also occur with other bee diseases, and should alert the beekeeper to ver ify which disease agent is present.
Figure 1
Clinical symptoms of American foulbrood: (a) mottled appearance of the brood often points out a brood disease and should alert the beekeeper. However, similar clinical symptoms may also occur with other diseases and necessitates further examination of the sample. Very char acteristic symptoms of American foulbrood are the dark brown glue-like larval remains (b), which dry down to a flat scale (c) and the decomposi tion of the pupal stage in which the tongue protrudes from the head (d).
Cultivation of Paenibacillus larvae
In 100 years of efforts to cultivate P. larvae, considerable progress has been made in the development of media promoting spore germination and growth, first attempted with an extract of larval honey bee tissue described by White (1907) . Over time, new culture media were devel oped or adapted for use in AFB diagnosis: J-agar (or J medium) (Gordon et al. 1973 ), brain-heart infusion agar supplemented with thiamine (Gochnauer 1973) , Mueller-Hinton broth, yeast extract, potassium phosphate, glucose and pyruvate agar (MYPGP) (Dingman and Stahly 1983) , Columbia blood agar (Plagemann 1985) , sheep blood agar (Lloyd 1986 ) and more recently, Paenibacillus larvae agar (PLA) (Schuch et al. 2001) . MYPGP (Nordstrom and Fries 1995) and PLA (Schuch et al. 2001) were shown to have superior plating efficacy. PLA offers the additional advant age that the majority of micro-organisms normally present in the hive and in bee products are inhibited. Moreover, this medium permits incubation in air, whereas previously prescribed media often demanded incubation under CO2 (Hornitzky and Nicholls 1993) .
As P. larvae is a spore-forming bacterium, its isolation from biological samples is typically preceded by a heat treatment step. This will significantly reduce the risk that P. larvae colonies will become obscured by rapidly grow ing competitors. Nevertheless, bacteria of the genera Bacillus, Paenibacillus and Brevibacillus may continue to swarm over the plates, most often when samples other than diseased larvae (honey, pollen or adult bees) are cul tured. This may necessitate the use of semi-selective media supplemented with nalidixic acid (Hornitzky and Clark 1991) and pipemidic acid (Alippi 1991 (Alippi , 1995 .
The type of samples that can be collected for diagnosis of a suspect bee colony has also been further expanded. When the symptoms are obvious, the sampler can cut out a piece of brood comb or collect the larval remains with a swab to be forwarded to the laboratory for further examination. Smears of the remains of diseased larvae for microscopic examination can also be taken in the field (Hornitzky and Wilson 1989) . When no symptoms are found, the early detection of spores will identify colonies at risk. Conse quently, measures can be taken to prevent the establish ment and further dissemination of the disease (de Graaf et al. 2001) . Apart from brood samples, analysis can be successfully conducted on honey from the brood nest or extracted from the supers (Shimanuki and Knox 1988; Hornitzky and Clark 1991) . Samples of pollen (Gochnauer and Corner 1974) , wax (Gochnauer 1981) , adult workers (Lindstrom and Fries 2005) or winter hive debris (Titéra and Haklova 2003) can also be used. Routine collection and analysis of samples can be part of an operational or regional AFB detection programme (Schuch et al. 2003) .
Molecular tools
The first PCR assay for the identification of P. larvae was developed by Govan et al. (1999) and was based on the 16S rRNA gene. Dobbelaere et al. (2001a) described a similar test, though the specificity of the latter was better found and a simplified protocol for the immediate analy sis of larval remains was provided. Neither test could dif ferentiate between the former Pll and Pip, a significant shortcoming during a period in which only Pll was con sidered the causative agent of AFB. Subsequently, several attempts were made to improve the specificity down to the former subspecies level using 16S rRNA-based PCR (Alippi et al. 2002; Piccini et al. 2002; Kilwinski et al. 2004 ) and others (Alippi et al. 2004a; Kilwinski et al. 2004; de Graaf et al. 2006) . With the reclassification of Pll and Pip into a single species, the scope of these more spe cific assays have become too narrow for purely diagnostic purposes. A novel nested PCR protocol of Lauro et al. (2003) permits direct analysis of honey and hive samples. This test is extremely sensitive to P. larvae DNA and might, consequently, identify levels of P. larvae that are below those likely to be important for disease.
Aside from PCR, several other molecular tools permit the identification and/or subtyping of the species P. larvae. SDS-PAGE of whole cell proteins gives a characteristic pro file for P. larvae (Hornitzky and Djordjevic 1992 ) and a subdivision into two clusters (Heyndrickx et al. 1996) , previously used to discriminate between the previously known subspecies Pll and Pip. Gas chromatography of methylated fatty acids provides a characteristic peak pattern that allows the identification of P. larvae (Drobnikova et al. 1994; Heyndrickx et al. 1996) . Several DNA fingerprinting techniques have been performed for epidemiological or taxonomic purposes: RFLP (restriction fragment length polymorphism) (Djordjevic et al. 1994) , ARDRA (ampli fied ribosomal DNA restriction analysis), RAPD (random amplified polymorphic DNA), AFLP (amplified fragment length polymorphism) (Heyndrickx et al. 1996) , PFGE (Wu et al. 2005) and PCR-based genotyping using primers corresponding to conserved motifs in bacterial repetitive REP (repetitive extragenic palindromic), ERIC (entero bacterial repetitive intergenic consensus) and BOX elements (Alippi and Aguilar 1998a,b) . For more infor mation on genotyping and virulence of P. larvae we refer to the recent review by Ashiralieva and Genersch (2006) .
Biochemical profile
The species P. larvae has a characteristic biochemical profile with acid from glucose and trehalose and no acid from ara binose and xylose (Gordon et al. 1973) . The testing of the carbohydrate acidification profile can be carried out by using homemade galleries (Gordon et al. 1973) or com mercialized kits (Carpana et al. 1995; Dobbelaere et al. 2001b; Neuendorf et al. 2004) . To our knowledge, only the BIOLOG system has an accompanying software tool that recognizes the P. /nrvne-specific biochemical profile. The result of the catalase test, which is negative for Pll, has to be broadened to include the delayed, weak positive reactions of P. larvae strains which were previously classified as Pip (Heyndrickx et al. 1996) . The production of high concen trations of proteolytic enzymes during vegetative growth and sporulation of P. larvae (reviewed by Chantawanakul and Dancer 2001) has long been utilized for diagnostic purposes in the Holst milk test (Holst 1946) . The enzy matic digestion of milk has now been formalized into a casein hydrolysis plate assay (Schuch et al. 2001) .
Bacteriophage sensitivity
Several bacteriophages have been isolated from P. larvae and phage sensitivity has been determined for bacterial strain typing (Drobnikova et al. 1994; Stahly et al. 1999 ). PPLlc, a virulent mutant bacteriophage isolated from a P. larvae field strain, lyses nearly all former Pll strains (97-99%; Stahly et al. 1999; Alippi et al. 2004b ). As species from the genera Bacillus, Brevibacillus and Paenibacillus (other than P. larvae} were proved to be resistant to PPLlc-induced lysis, phage sensitivity to PPLcl offers an interesting supplementary tool for P. larvae identifica tion (Fig. 2) (Stahly et al. 1999) .
Immunotechniques
Several different antibody-based techniques have been developed for diagnosis of AFB. These include the immunodiffusion test (Peng and Peng 1979) , the immu nofluorescence assay (Otte 1973) , where fluorochromeconjugated polyclonal antibodies are used to visualize specific bacteria (Toshkov et al. 1970; Zhavnenko 1971) , and the enzyme-linked immunosorbent assay using monoclonal antibodies (Olsen et al. 1990 ). Recently, a lateral flow device test kit for AFB detection has been developed (Vita, Hants, UK). It allows rapid confirmat ory diagnosis in the field and is now commercially avail able. The utility of each of these diagnostic tests is highly dependent on the specificity of the polyclonal or monoclonal antibody preparations used. Cross-recogni tion of closely related bacteria should be avoided.
Microscopy
The diagnosis of AFB by microscopic examination of car bol fuchsin-stained smears of dead larvae is entirely satis factory (Hornitzky and Wilson 1989) . The test is based on detecting P. larvae spores. The spores of P. alveian important secondary invader in cases of European foul brood which may cause AFB-like symptoms (see above)can be differentiated morphologically from P. larvae spores because they are larger (about 2-0 X 0-8 //m) and stain more deeply with carbol fuchsin than P. larvae spores which are 1-3 X 0-6 //m (Fig. 2) (Hornitzky and Wilson 1989) .
Conclusions and future prospects
With the new designation of the pathogenic agent of AFB, an important obstacle for the diagnosis of AFB has been eliminated. Molecular biological techniques have become increasingly accurate and sensitive for identifying P. larvae in honey bees and hive materials (Table 1 ). Nev ertheless, biochemical profiling and bacteriophage sensi tivity of suspect bacterial strains, microscopic examinations and immunotechniques provide entirely adequate alternatives (Table 1) .
In the future, it may also be possible to expand genetic ally based diagnoses to include specific traits of interest to P. larvae researchers and regulators (e.g. antibiotic resist ance, virulence and geographical source). With funding from the U.S. Department of Agriculture, an effort to sequence, assemble and annotate the P. larvae genome has been ongoing since 2004 (http://www.hgsc.bcm.tmc.edu/ projects/microbial/). This project is providing numerous candidates for genes involved in P. larvae pathogenesis (Evans and Pettis 2005) , along with polymorphic regions that can be used to develop new standardized tests for intraspecific boundaries. Having a genome sequence in hand should be especially helpful for identifying specific traits that make this such a virulent pathogenic agent and that regulate its activation during infection.
